ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO358

A Cross-Talk Between HIV-Injured Podocytes and Parietal Epithelial Cells (PECs) Results in Proliferation of PECs

Session Information

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation


  • Kumar, Vinod, Fienstine Institute for Medical Research, NEW YORK, New York, United States
  • Lan, Xiqian, Feinstein Institute for Medical Research, Manhasset, New York, United States
  • Ayasolla, Kamesh R., Feinstein Institute for Medical Research, Manhasset, New York, United States
  • Chowdhary, Sheetal, Feinstein Institute of Medical Research, New Hyde Park, New York, United States
  • Marashi Shoshtari, Seyedeh Shadafarin, The Feinstein Institute for Medical Research, Manhasset, New York, United States
  • Malhotra, Ashwani, Feinstein Institute Medical Research and NSLIJ, MANHASSET, New York, United States
  • Meyer-Schwesinger, Catherine, University of Hamburg, Hamburg, Germany
  • Skorecki, Karl, Rambam Health Care Campus, Haifa, Israel
  • Singhal, Pravin C., North Shore LIJ Health System, Great Neck, New York, United States

HIV-associated nephropathy is characterized by an abundance of proliferating PECs in Bowman’s space. The involved mechanism of PECs proliferation in HIV milieu is not clear. Interleukin (IL)-1 β has been reported to stimulate PECs proliferation. We have recently reported that HIV infection stimulates generation of IL-1β by PDs. We now hypothesize that a cross-talk between HIV-infected PDs and PECs would promote PECs proliferation.


Immortalized differentiated human PDs (DPDs) were transduced with either vector (DPDV) or HIV (NL4-3, DPDHIV) and assayed for pyroptosis (morphologic assay). Control DPDs and DPDHIV were incubated in serum-free media for 24 hours. Incubation (conditioned, C) media was collected and stored at -80°C. PECs were incubated in serum-free media containing 10% of control (DPDV) and experimental (DPDHIV) conditioned media for 48 hours. In another set of experiments, PECs were incubated in serum-free media containing 10% control and experimental media with or without IL-1β (neutralizing) antibodies for 48 hours. Cells were evaluated for proliferation by MTT cellular growth assay. To confirm the role of cross-talk, PECs were grown in outer wells and DPDV/DPDHIVs were seeded into inner wells (Trans-well plates). After 48 hours, cells in outer wells were assayed for proliferation. Cellular lysates/incubation media of DPDVs and DPDHIVs were assayed for IL-1β by ELISA. Additionally, PECs grown on coverslips were treated with 10% control and experimental media for 48 hours followed by immunolabeling for either PCNA or Ki67.


DPDHIV displayed a higher percentage of cells with pyroptosis (P<0.01 vs respective controls). Cellular lysates and incubation media of DPDHIV showed increased (P<0.05 vs. DPDV) content of IL-1β. Conditioned media of DPDHIV promoted PECs proliferation; however, anti-IL-1β antibody partially inhibited DPDHIV-conditioned media-mediated proliferation. PECs growing in outer wells of trans-well plates containing DPDHIV also displayed enhanced proliferation. PECs treated with DPDHIV conditioned media exhibited a higher percentage (P<0.01 vs. DPDV) of PCNA/Ki67 +ve cells.


A cross-talk between PDs to PECs promotes PECs proliferation in HIV milieu.


  • NIDDK Support